drugset / Trial / NCT01503944
A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
The purpose of this study is to evaluate the ability to identify individuals with dopaminergic degeneration in group of patients with a clinical diagnosis of either dementia with Lewy bodies (DLB) or idiopathic Parkinson's disease and to differentiate them from Alzheimer's disease (AD) and control subjects.
Timeline
- Start
- 2010-03
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-DTBZ | Diagnostic / imaging agent | 185 mbq | — |
| Subject | florbetapir F 18 | Diagnostic / imaging agent | 185 mbq | — |
| Subject | florbetapir F 18 | Diagnostic / imaging agent | 370 mbq | — |